We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.00 | -0.91% | 1,636.00 | 1,638.00 | 1,639.00 | 1,661.50 | 1,635.50 | 1,656.50 | 4,329,161 | 16:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.69 | 67.46B |
From Apr 2019 to Apr 2024
--GlaxoSmithKline (GSK), which is looking to sell its consumer healthcare business in India, has drawn bids from Nestle S.A (NSRGY), Unilever N.V. (UN) and Coca-Cola Co. (KO), Reuters reported Tuesday, citing "four people familiar with the mater."
--The sale of a 72.5% stake in its GlaxoSmithKline Consumer Healthcare is expected to bring in more than $4 billion, the report said.
--An offer was not made by Reckitt Benckiser Group PLC (RBGLY), although it is looking to strengthen its consumer health operation, the report said.
--The consumer healthcare business makes such products as malt beverage Horlicks and chocolate malt drink Boost, the report said.
Full story: https://www.reuters.com/article/us-gsk-m-a-india-exclusive/exclusive-nestle-unilever-coke-make-bids-in-4-billion-plus-gsk-india-sale-sources-idUSKCN1LY2GT
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 18, 2018 14:17 ET (18:17 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
